Indapta Therapeutics
San Francisco
About Indapta Therapeutics
Indapta Therapeutics is a privately held biotechnology company developing an NK (natural killer) cell therapy platform for the treatment of blood and solid tumor cancers.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $127.8M
- Last round: Series Unknown (Oct 2025)
- Website: indapta.com
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/indapta-therapeutics-38704 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.